Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services-part 6 of 6.
Aging
Alzheimer’s disease
Brain health services
Dementia
Equity
Prevention
Public health
Journal
Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643
Informations de publication
Date de publication:
11 10 2021
11 10 2021
Historique:
received:
29
01
2021
accepted:
04
08
2021
entrez:
12
10
2021
pubmed:
13
10
2021
medline:
29
10
2021
Statut:
epublish
Résumé
Brain Health Services are a novel approach to the personalized prevention of dementia. In this paper, we consider how such services can best reflect their social, cultural, and economic context and, in doing so, deliver fair and equitable access to risk reduction. We present specific areas of challenge associated with the social context for dementia prevention. The first concentrates on how Brain Health Services engage with the "at-risk" individual, recognizing the range of factors that shape an individual's risk of dementia and the efficacy of risk reduction measures. The second emphasizes the social context of Brain Health Services themselves and their ability to provide equitable access to risk reduction. We then elaborate proposals for meeting or mitigating these challenges. We suggest that considering these challenges will enable Brain Health Services to address two fundamental questions: the balance between an individualized "high-risk" and population focus for public health prevention and the ability of services to meet ethical standards of justice and health equity.
Identifiants
pubmed: 34635173
doi: 10.1186/s13195-021-00885-6
pii: 10.1186/s13195-021-00885-6
pmc: PMC8507368
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
173Subventions
Organisme : Medical Research Council
ID : G0601022
Pays : United Kingdom
Informations de copyright
© 2021. The Author(s).
Références
Frisoni GB, Molinuevo JL, Altomare D, Carrera E, Barkhof F, Berkhof J, et al. Precision prevention of Alzheimer’s and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies. Alzheimers Dementia. 2020 [cited 2020 Sep 22];n/a. Available from: https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.12132 ;16(10):1457–68.
doi: 10.1002/alz.12132
Altomare D, Molinuevo JL, Ritchie C, Ribaldi F, Carrera E, Dubois B, Jessen F, McWhirter L, Scheltens P, van der Flier WM, Vellas B, Démonet JF, Frisoni GB. Brain Health Services: Organization, structure and challenges for implementation. A user manual for Brain Health Services – Part 1 of 6. Alzheimer's Research & Therapy. 2021. https://doi.org/10.1186/s13195-021-00827-2 .
Ranson JM, Rittman T, Hayat S, Brayne C, Jessen F, Blennow K, van Duijn C, Barkhof F, Tang E, Mummery CJ, Stephan BCM, Altomare D, Frisoni GB, Ribaldi F, Molinuevo JL, Scheltens P, Llewellyn, DJ. Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services – Part 2 of 6. Alzheimer's Research & Therapy. 2021. https://doi.org/10.1186/s13195-021-00895-4 .
Visser LNC, Minguillon C, Sánchez-Benavides G, Abramowicz M, Altomare D, Fauria K, Frisoni GB, Georges J, Ribaldi F, Scheltens P, van der Schaar J, Zwan M, van der Flier WM, Molinuevo JL. Dementia risk communication. A user manual for Brain Health Services – Part 3 of 6. Alzheimer's Research & Therapy. 2021. https://doi.org/10.1186/s13195-021-00840-5 .
Solomon A, Stephen R, Altomare D, Carrera E, Frisoni GB, Kulmala J, Molinuevo JL, Nilsson P, Ngandu T, Ribaldi F, Vellas B, Scheltens P, Kivipelto M. Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services – Part 4 of 6. Alzheimer's Research & Therapy. 2021. https://doi.org/10.1186/s13195-021-00875-8 .
Brioschi Guevara A, Bieler M, Altomare D, Berthier M, Csajka C, Dautricourt S, Démonet JF, Dodich A, Frisoni GB, Miniussi C, Molinuevo JL, Ribaldi F, Scheltens P, Chételat G. Protocols for cognitive enhancement. A user manual for Brain Health Services – Part 5 of 6. Alzheimer's Research & Therapy. 2021. https://doi.org/10.1186/s13195-021-00844-1 .
Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol. 2014;13(8):788–94. https://doi.org/10.1016/S1474-4422(14)70136-X .
doi: 10.1016/S1474-4422(14)70136-X
pubmed: 25030513
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;0 Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30367-6/abstract . [cited 2020 Jul 31].
Wu Y-T, Fratiglioni L, Matthews FE, Lobo A, Breteler MMB, Skoog I, et al. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol. 2016;15(1):116–24. https://doi.org/10.1016/S1474-4422(15)00092-7 .
doi: 10.1016/S1474-4422(15)00092-7
pubmed: 26300044
Wolters FJ, Chibnik LB, Waziry R, Anderson R, Berr C, Beiser A, et al. 27-year time trends in dementia incidence in Europe and the US: the Alzheimer Cohorts Consortium. Neurology. 2020;95(5):e519–31. https://doi.org/10.1212/WNL.0000000000010022 .
doi: 10.1212/WNL.0000000000010022
pubmed: 32611641
pmcid: 7455342
Marmot M, Allen J, Goldblatt P, Boyce T, McNeish D, Grady M. Fair society, healthy lives: the Marmot Review: strategic review of health inequalities in England post-2010. 2010. London: Department of International Development; 2019.
Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimäki M, Batty GD. Socioeconomic status as a risk factor for dementia death: individual participant meta-analysis of 86 508 men and women from the UK. Br J Psychiatry. 2013;203:10–7.
doi: 10.1192/bjp.bp.112.119479
Weuve J, Barnes LL, Mendes de Leon CF, Rajan KB, Beck T, Aggarwal NT, et al. Cognitive aging in black and white Americans: cognition, cognitive decline, and incidence of Alzheimer disease dementia. Epidemiology. 2018;29(1):151–9. https://doi.org/10.1097/EDE.0000000000000747 .
doi: 10.1097/EDE.0000000000000747
pubmed: 28863046
pmcid: 5718953
Barnes LL, Bennett DA. Alzheimer’s disease in african americans: risk factors and challenges for the future. Health Aff. 2014;33(4):580–6. https://doi.org/10.1377/hlthaff.2013.1353 .
doi: 10.1377/hlthaff.2013.1353
Brayne C, Matthews FE. The determinants of cognitive decline and dementia. BMJ. 2019;366:l4946. https://doi.org/10.1136/bmj.l4946 .
French DP, Cameron E, Benton JS, Deaton C, Harvie M. Can communicating personalised disease risk promote healthy behaviour change? A systematic review of systematic reviews. Ann Behav Med. 2017;51(5):718–29. https://doi.org/10.1007/s12160-017-9895-z .
doi: 10.1007/s12160-017-9895-z
pubmed: 28290066
Usher-Smith JA, Silarova B, Schuit E, Moons KG, Griffin SJ. Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review. BMJ Open. 2015;5:e008717.
doi: 10.1136/bmjopen-2015-008717
Hollands GJ, French DP, Griffin SJ, Prevost AT, Sutton S, King S, et al. The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis. BMJ. 2016;352:i1102. https://doi.org/10.1136/bmj.i1102 .
doi: 10.1136/bmj.i1102
pubmed: 26979548
pmcid: 4793156
Angehrn Z, Sostar J, Nordon C, Turner A, Gove D, Karcher H, et al. Ethical and Social implications of using predictive modeling for Alzheimer’s disease prevention: a systematic literature review. J Alzheimers Dis. 2020;76:923–40.
doi: 10.3233/JAD-191159
Barnes LL, Arvanitakis Z, Yu L, Kelly J, Jager PLD, Bennett DA. Apolipoprotein E and change in episodic memory in Blacks and Whites. NED. 2013;40:211–9.
Raman R, Quiroz YT, Langford O, Choi J, Ritchie M, Baumgartner M, et al. Disparities by race and ethnicity among adults recruited for a preclinical Alzheimer disease trial. JAMA Netw Open. 2021;4(7):e2114364. https://doi.org/10.1001/jamanetworkopen.2021.14364 .
doi: 10.1001/jamanetworkopen.2021.14364
pubmed: 34228129
pmcid: 8261604
Sirugo G, Williams SM, Tishkoff SA. The missing diversity in human genetic studies. Cell. 2019;177(1):26–31. https://doi.org/10.1016/j.cell.2019.02.048 .
doi: 10.1016/j.cell.2019.02.048
pubmed: 30901543
pmcid: 7380073
Goerdten J, Čukić I, Danso SO, Carrière I, Muniz-Terrera G. Statistical methods for dementia risk prediction and recommendations for future work: a systematic review. Alzheimers Dementia. 2019;5(1):563–9. https://doi.org/10.1016/j.trci.2019.08.001 .
doi: 10.1016/j.trci.2019.08.001
Stephan BCM, Kurth T, Matthews FE, Brayne C, Dufouil C. Dementia risk prediction in the population: are screening models accurate? Nat Rev Neurol. 2010;6(6):318–26. https://doi.org/10.1038/nrneurol.2010.54 .
doi: 10.1038/nrneurol.2010.54
pubmed: 20498679
Tang EYH, Harrison SL, Errington L, Gordon MF, Visser PJ, Novak G, et al. Current developments in dementia risk prediction modelling: an updated systematic review. PLoS One. 2015;10(9):e0136181. https://doi.org/10.1371/journal.pone.0136181 .
doi: 10.1371/journal.pone.0136181
pubmed: 26334524
pmcid: 4559315
van Maurik IS, Vos SJ, Bos I, Bouwman FH, Teunissen CE, Scheltens P, et al. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. Lancet Neurol. 2019;18(11):1034–44. https://doi.org/10.1016/S1474-4422(19)30283-2 .
doi: 10.1016/S1474-4422(19)30283-2
pubmed: 31526625
Solomon A, Turunen H, Ngandu T, Peltonen M, Levälahti E, Helisalmi S, et al. Effect of the apolipoprotein E genotype on cognitive change during a multidomain lifestyle intervention: a subgroup analysis of a randomized clinical trial. JAMA Neurol. 2018;75(4):462–70. https://doi.org/10.1001/jamaneurol.2017.4365 .
doi: 10.1001/jamaneurol.2017.4365
pubmed: 29356827
pmcid: 29356827
Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017;16(5):377–89. https://doi.org/10.1016/S1474-4422(17)30040-6 .
doi: 10.1016/S1474-4422(17)30040-6
pubmed: 28359749
pmcid: 28359749
Richard E, Moll van Charante EP, Hoevenaar-Blom MP, Coley N, Barbera M, van der Groep A, et al. Healthy ageing through internet counselling in the elderly (HATICE): a multinational, randomised controlled trial. Lancet Digital Health. 2019;1:e424–34.
doi: 10.1016/S2589-7500(19)30153-0
Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42. https://doi.org/10.1186/1748-5908-6-42 .
doi: 10.1186/1748-5908-6-42
pubmed: 21513547
pmcid: 3096582
Wendel-Vos GCW, Dutman AE, Verschuren WMM, Ronckers ET, Ament A, van Assema P, et al. Lifestyle factors of a five-year community-intervention program: the Hartslag Limburg intervention. Am J Prev Med. 2009;37(1):50–6. https://doi.org/10.1016/j.amepre.2009.03.015 .
doi: 10.1016/j.amepre.2009.03.015
pubmed: 19524144
McGill R, Anwar E, Orton L, Bromley H, Lloyd-Williams F, O’Flaherty M, et al. Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact. BMC Public Health. 2015;15(1):457. https://doi.org/10.1186/s12889-015-1781-7 .
doi: 10.1186/s12889-015-1781-7
pubmed: 25934496
pmcid: 4423493
Hart JT. The Inverse Care Law. Lancet. 1971;297(7696):405–12. https://doi.org/10.1016/S0140-6736(71)92410-X .
doi: 10.1016/S0140-6736(71)92410-X
Fowler NR, Perkins AJ, Gao S, Sachs GA, Boustani MA. Risks and benefits of screening for dementia in primary care: the Indiana University cognitive health outcomes investigation of the comparative effectiveness of dementia screening (IU CHOICE) trial. J Am Geriatr Soc. 2020;68(3):535–43. https://doi.org/10.1111/jgs.16247 .
Annas GJ, Elias S. 23andMe and the FDA. N Engl J Med. 2014;370(11):985–8. https://doi.org/10.1056/NEJMp1316367 .
doi: 10.1056/NEJMp1316367
pubmed: 24520936
Schaper M, Schicktanz S. Medicine, market and communication: ethical considerations in regard to persuasive communication in direct-to-consumer genetic testing services. BMC Med Ethics. 2018;19(1):56. https://doi.org/10.1186/s12910-018-0292-3 .
doi: 10.1186/s12910-018-0292-3
pubmed: 29871685
pmcid: 5989449
Capewell S, Graham H. Will cardiovascular disease prevention widen health inequalities? PLoS Med. 2010;7:e1000320.
doi: 10.1371/journal.pmed.1000320
Cahill S, Pierce M, Moore V. A national survey of memory clinics in the Republic of Ireland. Int Psychogeriatr. 2014;26(4):605–13. https://doi.org/10.1017/S104161021300238X .
doi: 10.1017/S104161021300238X
pubmed: 24382116
Morgan DG, Crossley M, Kirk A, D’Arcy C, Stewart N, Biem J, et al. Improving access to dementia care: development and evaluation of a rural and remote memory clinic. null. Routledge. 2009;13:17–30.
Szymczynska P, Innes A, Mason A, Stark C. A review of diagnostic process and postdiagnostic support for people with dementia in rural areas. J Prim Care Community Health. 2011;2(4):262–76. https://doi.org/10.1177/2150131911404705 .
doi: 10.1177/2150131911404705
pubmed: 23804844
Savva GM, Arthur A. Who has undiagnosed dementia? A cross-sectional analysis of participants of the Aging, Demographics and Memory Study. Age Ageing. 2015;44(4):642–7. https://doi.org/10.1093/ageing/afv020 .
doi: 10.1093/ageing/afv020
pubmed: 25758406
pmcid: 4560041
Lang L, Clifford A, Wei L, Zhang D, Leung D, Augustine G, et al. Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis. BMJ Open. 2017;7(2):e011146. https://doi.org/10.1136/bmjopen-2016-011146 .
doi: 10.1136/bmjopen-2016-011146
pubmed: 28159845
pmcid: 5293981
Amjad H, Roth DL, Sheehan OC, Lyketsos CG, Wolff JL, Samus QM. Underdiagnosis of dementia: an observational study of patterns in diagnosis and awareness in US older adults. J Gen Intern Med. 2018;33(7):1131–8. https://doi.org/10.1007/s11606-018-4377-y .
doi: 10.1007/s11606-018-4377-y
pubmed: 29508259
pmcid: 6025653
Cooper C, Lodwick R, Walters K, Raine R, Manthorpe J, Iliffe S, et al. Observational cohort study: deprivation and access to anti-dementia drugs in the UK. Age Ageing. 2016;45(1):148–54. https://doi.org/10.1093/ageing/afv154 .
doi: 10.1093/ageing/afv154
pubmed: 26582758
Qian W, Schweizer TA, Fischer CE. Impact of socioeconomic status on initial clinical presentation to a memory disorders clinic. Int Psychogeriatr. 2014;26(4):597–603. https://doi.org/10.1017/S1041610213002299 .
doi: 10.1017/S1041610213002299
pubmed: 24331159
Cooper C, Tandy AR, Balamurali TBS, Livingston G. A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care, and research. Am J Geriatr Psychiatry. 2010;18(3):193–203. https://doi.org/10.1097/JGP.0b013e3181bf9caf .
doi: 10.1097/JGP.0b013e3181bf9caf
pubmed: 20224516
Lin P-J, Daly AT, Olchanski N, Cohen JT, Neumann PJ, Faul JD, et al. Dementia diagnosis disparities by race and ethnicity. Med Care. 2021;59(8):679–86. https://doi.org/10.1097/MLR.0000000000001577 .
doi: 10.1097/MLR.0000000000001577
pubmed: 34091580
Gianattasio KZ, Prather C, Glymour MM, Ciarleglio A, Power MC. Racial disparities and temporal trends in dementia misdiagnosis risk in the United States. Alzheimers Dement. 2019;5:891–8. https://doi.org/10.1016/j.trci.2019.11.008 .
doi: 10.1016/j.trci.2019.11.008
Pham TM, Petersen I, Walters K, Raine R, Manthorpe J, Mukadam N, et al. Trends in dementia diagnosis rates in UK ethnic groups: analysis of UK primary care data. Clin Epidemiol. 2018;10:949–60. https://doi.org/10.2147/CLEP.S152647 .
doi: 10.2147/CLEP.S152647
pubmed: 30123007
pmcid: 6087031
Ogliari G, Turner Z, Khalique J, Gordon AL, Gladman JRF, Chadborn NH. Ethnic disparity in access to the memory assessment service between South Asian and white British older adults in the United Kingdom: a cohort study. Int J Geriatric Psychiatry. 2020;35(5):507–15. https://doi.org/10.1002/gps.5263 .
doi: 10.1002/gps.5263
Mukadam N, Cooper C, Livingston G. Improving access to dementia services for people from minority ethnic groups. Curr Opin Psychiatry. 2013;26(4):409–14. https://doi.org/10.1097/YCO.0b013e32835ee668 .
doi: 10.1097/YCO.0b013e32835ee668
pubmed: 23454888
pmcid: 4222802
Berwald S, Roche M, Adelman S, Mukadam N, Livingston G. Black African and Caribbean British communities’ perceptions of memory problems: “We Don’t Do Dementia”. PLoS One. 2016;11 Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821595/ . [cited 2020 Jul 17].
Mukadam N, Cooper C, Basit B, Livingston G. Why do ethnic elders present later to UK dementia services? A qualitative study. Int Psychogeriatr. 2011;23(7):1070–7. https://doi.org/10.1017/S1041610211000214 .
doi: 10.1017/S1041610211000214
pubmed: 21349212
Stites SD, Rubright JD, Karlawish J. What features of stigma do the public most commonly attribute to Alzheimer’s disease dementia? Results of a survey of the U.S. general public. Alzheimers Dement. 2018;14:925–32.
doi: 10.1016/j.jalz.2018.01.006
Stites SD, Milne R, Karlawish J. Advances in Alzheimer’s imaging are changing the experience of Alzheimer’s disease. Alzheimers Dement. 2018;10:285–300. https://doi.org/10.1016/j.dadm.2018.02.006 .
Krogsbøll LT, Jørgensen KJ, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev. 2019; [cited 2020 Jul 31]; Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009009.pub3/full .
Kypridemos C, Collins B, McHale P, Bromley H, Parvulescu P, Capewell S, et al. Future cost-effectiveness and equity of the NHS Health Check cardiovascular disease prevention programme: microsimulation modelling using data from Liverpool, UK. PLoS Med. 2018;15:e1002573.
doi: 10.1371/journal.pmed.1002573
Rutter H, Savona N, Glonti K, Bibby J, Cummins S, Finegood DT, et al. The need for a complex systems model of evidence for public health. Lancet. 2017;390(10112):2602–4. https://doi.org/10.1016/S0140-6736(17)31267-9 .
doi: 10.1016/S0140-6736(17)31267-9
pubmed: 28622953
John SD. Risk, contractualism, and Rose’s “prevention paradox”. Soc Theory Pract. 2014;40:28–50.
doi: 10.5840/soctheorpract20144012
Rose G. Sick Individuals and sick populations. Int J Epidemiol. 1985;14(1):32–8. https://doi.org/10.1093/ije/14.1.32 .
doi: 10.1093/ije/14.1.32
pubmed: 3872850
Molinuevo JL, Cami J, Carné X, Carrillo MC, Georges J, Isaac MB, et al. Ethical challenges in preclinical Alzheimer’s disease observational studies and trials: results of the Barcelona summit. Alzheimers Dement. 2016;12(5):614–22. https://doi.org/10.1016/j.jalz.2016.01.009 .
doi: 10.1016/j.jalz.2016.01.009
pubmed: 26988427
pmcid: 4861656
Prince M. Progress on dementia—leaving no one behind. Lancet. 2017;390(10113):e51–3. https://doi.org/10.1016/S0140-6736(17)31757-9 .
doi: 10.1016/S0140-6736(17)31757-9
pubmed: 28735856
Gostin LO, Powers M. What does social justice require for the public’s health? Public Health Ethics And Policy Imperatives. Health Aff. 2006;25(4):1053–60. https://doi.org/10.1377/hlthaff.25.4.1053 .
doi: 10.1377/hlthaff.25.4.1053
Beauchamp DE. Public health as social justice. Inquiry. 1976;13:3–14.
pubmed: 130348
pmcid: 130348